EGFR and breast carcinoma: EVs modified with GE11 peptide, a synthetic peptide that binds specifically to EGFR, could efficiently deliver let-7a miRNA to EGFR-expressing xenograft breast cancer tissues in mice, leading to a marked inhibition of tumor growth 114.